 SEATTLE, Jan. 25, 2021 GLOBE NEWSWIRE -- Atossa Therapeutics, Inc. Nasdaq:ATOS, a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that Dr. Steven C. Quay, President and CEO, will speak as a panelist at the 2021 Precision Medicine World Conference 21st Century Precision Medicine in the Age of COVID-19 